Gibson, Dunn & Crutcher announced that Christian Riis-Madsen will join the firm’s Brussels office as a partner in the firm’s Antitrust and Competition Practice Group. Riis-Madsen joins the firm from O’Melveny & Myers.
“We are delighted that Christian is joining us,” said Ken Doran, Chairman and Managing Partner of Gibson Dunn. “He is highly regarded in the Brussels legal and business communities and is well-known to many of our partners and several of our clients. He has a well-rounded competition practice with deep experience with top multinational technology companies. Moreover, he has demonstrated strong leadership qualities and will complement the strengths of our global Antitrust and Competition Practice Group.”
“Christian is a super fit to our existing Brussels practice, both in terms of his great legal skills and his personality,” said Peter Alexiadis, Partner in Charge of the Brussels office. “Christian has been on our radar for some time. His reputation in the high tech sector fits very well with our existing client base, while significant synergies also present themselves in the growth of our existing Scandinavian/Nordic practice.”
“I am looking forward to working with my new colleagues at Gibson Dunn,” said Riis-Madsen. “The firm’s premier competition practice and technology clientele are a perfect platform to continue to grow my practice.”
Full Content: Gibson, Dunn & Crutcher
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan